These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25353163)

  • 21. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
    Liu Z; Jiang Z; Huang J; Huang S; Li Y; Yu S; Yu S; Liu X
    Int J Oncol; 2014 May; 44(5):1571-80. PubMed ID: 24603851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LRIG1 enhances cisplatin sensitivity of glioma cell lines.
    Wang X; Xiao Q; Xing X; Tian C; Zhang H; Ye F; Wan F; Wang B; Guo D; Lei T
    Oncol Res; 2012; 20(5-6):205-11. PubMed ID: 23581227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRIG1 extracellular domain: structure and function analysis.
    Xu Y; Soo P; Walker F; Zhang HH; Redpath N; Tan CW; Nicola NA; Adams TE; Garrett TP; Zhang JG; Burgess AW
    J Mol Biol; 2015 May; 427(10):1934-48. PubMed ID: 25765764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.
    Cheng SQ; Fan HY; Xu X; Gao WW; Lv SG; Ye MH; Wu MJ; Shen XL; Cheng ZJ; Zhu XG; Zhang Y
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):558-563. PubMed ID: 27465333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
    Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
    Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.
    Johansson M; Oudin A; Tiemann K; Bernard A; Golebiewska A; Keunen O; Fack F; Stieber D; Wang B; Hedman H; Niclou SP
    Neuro Oncol; 2013 Sep; 15(9):1200-11. PubMed ID: 23723255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
    Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
    J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.
    Ding J; Liu B; He Y; Yuan X; Tian D; Ji B; Wang L; Wu L; Dong H; Wang J; Zhu X; Cai Q; Zhang S; Chen Q
    Cell Biochem Biophys; 2015 Jan; 71(1):27-33. PubMed ID: 25449296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
    Yan ZJ; Cheng Y; Jiang JH; Hu JS; Shi XD
    Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):732-6. PubMed ID: 23157908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
    Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
    Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
    Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gambogic acid induces EGFR degradation and Akt/mTORC1 inhibition through AMPK dependent-LRIG1 upregulation in cultured U87 glioma cells.
    He XY; Liu XJ; Chen X; Bian LG; Zhao WG; Shen JK; Sun QF
    Biochem Biophys Res Commun; 2013 Jun; 435(3):397-402. PubMed ID: 23665322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications.
    Mao F; Wang B; Xiao Q; Cheng F; Lei T; Guo D
    J Neurol Sci; 2017 Dec; 383():56-60. PubMed ID: 29246624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular mechanism of LRIG1 cDNA-induced apoptosis in human glioma cell line H4].
    Ye F; Guo DS; Niu HQ; Tao SZ; Ou YB; Lu YP; Lei T
    Ai Zheng; 2004 Oct; 23(10):1149-54. PubMed ID: 15473925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of LRIG1, a Negative Regulator of EGFR, Is Dynamically Altered during Different Stages of Gastric Carcinogenesis.
    Yu S; Yang M; Lim KM; Cho Y; Kim H; Lee K; Jeong SH; Coffey RJ; Goldenring JR; Nam KT
    Am J Pathol; 2018 Dec; 188(12):2912-2923. PubMed ID: 30248341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
    Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
    J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
    Wu X; Hedman H; Bergqvist M; Bergström S; Henriksson R; Gullbo J; Lennartsson J; Hesselius P; Ekman S
    Acta Oncol; 2012 Jan; 51(1):69-76. PubMed ID: 21417672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
    Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
    Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
    Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
    Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.